Application Information

This drug has been submitted to the FDA under the reference 202067/001.

Names and composition

"ONFI" is the commercial name of a drug composed of CLOBAZAM.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202067/001 ONFI CLOBAZAM TABLET/ORAL 5MG
202067/002 ONFI CLOBAZAM TABLET/ORAL 10MG
202067/003 ONFI CLOBAZAM TABLET/ORAL 20MG
203993/001 ONFI CLOBAZAM SUSPENSION/ORAL 2.5MG per ML

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
202067/001 ONFI CLOBAZAM TABLET/ORAL 5MG
202067/002 ONFI CLOBAZAM TABLET/ORAL 10MG
202067/003 ONFI CLOBAZAM TABLET/ORAL 20MG
203993/001 ONFI CLOBAZAM SUSPENSION/ORAL 2.5MG per ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved